The effects of transcranial magnetic stimulation for freezing of gait in Parkinson’s disease: a systematic review and meta-analysis of randomized controlled trials
Open Access
- 2 February 2024
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Aging Neuroscience
- Vol. 16, 1304852
Abstract
Background: Freezing of gait (FOG) is one of the most disabling gait disturbances in Parkinson’s disease (PD), affecting mobility and balance severely, thereby leading to an increased risk of falls.Objectives: The purpose of this systematic review and meta-analysis was to investigate the effects of transcranial magnetic stimulation on FOG in PD.Methods: Based on PRISMA guidelines, we searched the databases of MEDLINE (PubMed), Cochrane Library, PEDro, Embase, and Web of Science. Studies of the English language published up to July 2023 were searched. We retrieved for studies of randomized controlled trials (RCTs) of transcranial magnetic stimulation to treat FOG after PD and screened by inclusion and exclusion criteria. Risk of bias was assessed using the Cochrane Collaboration’s tool (Revman5.30). Characteristics of RCTs were extracted. The heterogeneity of the trials was measured by I2 statistic. The effect size was expressed by a standardized mean difference (SMD) with a 95% confidence interval (CI).Results: A total of 488 articles were screened, after screening sixteen RCTs involved in 408 patients were included in the qualitative analysis, and 15 RCTs were included in meta-analysis. The outcome measures included FOG-Q, walking time, TUG, and UPDRS. Six studies used FOG-Q as outcome measure, six studies used walking time, four studies used TUG, and six studies used UPDRS. Compared with placebo treatment, transcranial magnetic stimulation has positive significant effects in improving gait status with increased walking speed (SMD = −0.41, 95% CI = −0.75 to −0.06, I2 = 7% p = 0.02), FOG-Q scores (SMD = −0.55, 95% CI = −0.89 to −0.21, I2 = 29%, p = 0.002), UPDRS scores (SMD = −1.08, 95% CI = −1.39 to −0.78, I2 = 49%, P < 0.001) and the time of TUG (SMD = −0.56, 95% CI = −0.88 to −0.23, I2 = 25%, p = 0.02) decreased.Conclusion: Transcranial magnetic stimulation could significantly improving gait conditions in PD patients with FOG.Systematic review registration: https://www.crd.york.ac.uk/PROSPERO/#recordDetails, CRD42023434286.Keywords
This publication has 53 references indexed in Scilit:
- Freezing of gait: moving forward on a mysterious clinical phenomenonThe Lancet Neurology, 2011
- Intermittent theta-burst transcranial magnetic stimulation for treatment of Parkinson diseaseNeurology, 2011
- Controlled trial on the effect of 10 days low‐frequency repetitive transcranial magnetic stimulation (rTMS) on motor signs in Parkinson's diseaseMovement Disorders, 2010
- Effect of transcranial magnetic stimulation on Parkinson motor function—Systematic review of controlled clinical trialsMovement Disorders, 2009
- Functional role of the supplementary and pre-supplementary motor areasNature Reviews Neuroscience, 2008
- Clinimetrics of freezing of gaitMovement Disorders, 2008
- Quality of life in Parkinson's disease: The relative importance of the symptomsMovement Disorders, 2008
- Repetitive transcranial stimulation for freezing of gait in Parkinson's diseaseMovement Disorders, 2007
- Transcranial magnetic stimulation over dorsolateral prefrontal cortex in Parkinson’s diseaseClinical Neurophysiology, 2007
- Repetitive magnetic stimulation of cortical motor areas in Parkinson's disease: Implications for the pathophysiology of cortical functionMovement Disorders, 2001